Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway (original) (raw)

• _info_Info
  • Article information
  • Full-Text
  • Figures and Tables
  • References (53)
  • Cited By (199)
  • Supplementary Material
  • Metrics
• _list_Sections

Abstract

Hepatitis C virus (HCV) persists in the majority of infected individuals and is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Chronic hepatitis C is currently treated with interferon (IFN)-α or with a combination of IFN-α and ribavirin. The availability of an HCV replicon system (Lohmann et al., Science 285, 110–113, 1999) allowed the investigation of the effects of IFN on genuine HCV replication in cultured cells. It is shown here that IFN-α inhibits subgenomic HCV RNA replication in HuH-7 human hepatoma cells. Immunofluorescence, Western blot and Northern blot analysis revealed that levels of both HCV protein and replicon RNA were reduced after treatment with IFN-α in a dose-dependent manner. In further experiments, it was investigated whether MxA plays a role in the inhibition of HCV. The human MxA protein is an IFN-induced GTPase that has antiviral activity against various RNA viruses. However, HCV RNA replication was not affected in transfected HuH-7 cells that transiently overexpressed MxA. Moreover, a dominant-negative mutant of MxA did not interfere with the antiviral activity of IFN-α against HCV RNA replication. Taken together, these results demonstrate that IFN-α inhibits HCV replicons via an MxA-independent pathway.

• Received: 23/11/2000
• Accepted:11/01/2001
• Published Online:01/04/2001

© Microbiology Society

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-4-723

2001-04-01

2025-03-13

Full text loading...

Most read this month

Article

content/journal/jgv

Journal

5

3

false

en